Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Latvia |
First Approval Date03 Aug 2021 |
100 Clinical Results associated with Rigvir Sia
0 Patents (Medical) associated with Rigvir Sia
100 Deals associated with Rigvir Sia
100 Translational Medicine associated with Rigvir Sia